DK9390A - Kondenserede benzapiner - Google Patents

Kondenserede benzapiner Download PDF

Info

Publication number
DK9390A
DK9390A DK009390A DK9390A DK9390A DK 9390 A DK9390 A DK 9390A DK 009390 A DK009390 A DK 009390A DK 9390 A DK9390 A DK 9390A DK 9390 A DK9390 A DK 9390A
Authority
DK
Denmark
Prior art keywords
benzapines
condensed
compounds
transisomeric
benzazepines
Prior art date
Application number
DK009390A
Other languages
English (en)
Other versions
DK9390D0 (da
DK162889C (da
DK162889B (da
Inventor
Joel Gilbert Berger
Wei Kong Chang
Elijah Herman Gold
John Welch Clader
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DK9390D0 publication Critical patent/DK9390D0/da
Publication of DK9390A publication Critical patent/DK9390A/da
Publication of DK162889B publication Critical patent/DK162889B/da
Application granted granted Critical
Publication of DK162889C publication Critical patent/DK162889C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/32—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Electroluminescent Light Sources (AREA)
  • Luminescent Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK009390A 1987-07-15 1990-01-12 Substituerede hexahydrobenzindenoazepiner, fremgangsmaader til fremstilling af saadanne forbindelser, farmaceutiske praeparater indeholdende forbindelserne, anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater samt fremgangsmaade til fremstilling af saadanne farmaceutiske praeparater DK162889C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/US1987/001636 WO1989000561A1 (en) 1987-07-15 1987-07-15 Fused benzazepines
US8701636 1987-07-15
EP87110253 1987-07-16
EP87110253A EP0299101B1 (en) 1987-07-15 1987-07-16 Fused benzazepines

Publications (4)

Publication Number Publication Date
DK9390D0 DK9390D0 (da) 1990-01-12
DK9390A true DK9390A (da) 1990-03-12
DK162889B DK162889B (da) 1991-12-23
DK162889C DK162889C (da) 1992-05-11

Family

ID=26108265

Family Applications (1)

Application Number Title Priority Date Filing Date
DK009390A DK162889C (da) 1987-07-15 1990-01-12 Substituerede hexahydrobenzindenoazepiner, fremgangsmaader til fremstilling af saadanne forbindelser, farmaceutiske praeparater indeholdende forbindelserne, anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater samt fremgangsmaade til fremstilling af saadanne farmaceutiske praeparater

Country Status (13)

Country Link
EP (2) EP0363353B1 (da)
JP (1) JPH0678317B2 (da)
AT (1) ATE78467T1 (da)
AU (1) AU617651B2 (da)
DE (1) DE3780649T2 (da)
DK (1) DK162889C (da)
ES (1) ES2043623T3 (da)
FI (1) FI93212C (da)
GR (1) GR3006671T3 (da)
HU (1) HU203537B (da)
NO (1) NO177264C (da)
WO (1) WO1989000561A1 (da)
ZA (1) ZA875183B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973586A (en) 1986-01-16 1990-11-27 Schering Corporation Fused benzazepines, compositions of, and medical use thereof
PL168408B1 (pl) * 1989-08-03 1996-02-29 Smithkline Beecham Biolog Sposób wytwarzania stransformowanego mikroorganizmu PL
WO1991011437A1 (en) * 1990-02-02 1991-08-08 Schering Corporation 4,5-cycloalkano-3-benzazepin-7-ol-derivatives and their use
JPH07137816A (ja) * 1993-11-15 1995-05-30 Tokai Univ 地下空洞内貯蔵装置
US7211574B2 (en) * 2002-08-29 2007-05-01 Schering Corporation Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders
WO2005035504A2 (en) * 2003-05-22 2005-04-21 Schering Corporation 5-h -benzo [d] naphth [2, 1-b] azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
CH481110A (de) * 1967-02-17 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
US4680298A (en) * 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents
WO1987004430A2 (en) * 1986-01-16 1987-07-30 Schering Corporation Fused benzazepines

Also Published As

Publication number Publication date
EP0299101A1 (en) 1989-01-18
ES2043623T3 (es) 1994-01-01
GR3006671T3 (da) 1993-06-30
JPH0678317B2 (ja) 1994-10-05
FI93212C (fi) 1995-03-10
DE3780649D1 (de) 1992-08-27
ZA875183B (en) 1988-04-08
FI93212B (fi) 1994-11-30
EP0363353B1 (en) 1992-07-22
DE3780649T2 (de) 1992-12-10
AU8037887A (en) 1989-02-13
NO900186L (no) 1990-01-12
NO177264B (no) 1995-05-08
NO177264C (no) 1995-08-16
DK9390D0 (da) 1990-01-12
JPH02504629A (ja) 1990-12-27
WO1989000561A1 (en) 1989-01-26
FI900175A0 (fi) 1990-01-12
HU203537B (en) 1991-08-28
NO900186D0 (no) 1990-01-12
AU617651B2 (en) 1991-12-05
DK162889C (da) 1992-05-11
EP0363353A1 (en) 1990-04-18
DK162889B (da) 1991-12-23
ATE78467T1 (de) 1992-08-15
EP0299101B1 (en) 1992-09-23

Similar Documents

Publication Publication Date Title
EA199800946A1 (ru) Концентрированный препарат антител
DK442688A (da) Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser
DE68903846D1 (de) Neue galenische form von fenofibrat.
DE3782658D1 (de) Ionen-beweglichkeits-spektrometer.
NO875045D0 (no) Fremgangsmaate for fremstilling av topiske preparater for behandling av akne.
DK479087A (da) Kondenserede benzazepiner
DE3873127D1 (de) Therapeutische praeparate.
DK0482097T3 (da) Tensidpræparater og fremgangsmåder
ES2088965T3 (es) Derivados de rodanina aril-sustituidos.
NL960005I2 (nl) Optisch zuivere verbinding, en werkwijze voor de bereiding daarvan.
FI873798A0 (fi) Aminoglykosidsteroider, foerfarande foer deras framstaellning, deras anvaendning samt farmaceutiska kompositioner innehaollande desamma.
DE3881579D1 (de) Ionenquelle.
DK9390A (da) Kondenserede benzapiner
NO874193D0 (no) Farmasoeytiske preparater.
FI873799A (fi) Aminoglykosidsteroider, foerfarande foer deras framstaellning, deras anvaendning samt farmaceutiska kompositioner innehaollande desamma.
NO873213D0 (no) Fremgangsmaate for fremstilling av transdermale preparater.
ATE66478T1 (de) 12- und 13-substituierte ergolinderivate.
NO883609L (no) Farmasoeytiske preparater for topisk anvendelse.
DE69006704D1 (de) Trifunktionelle Polyoxyethylenediaminderivate.
NO903599D0 (no) Minoxidilgel.
IT8705102A0 (it) Derivati di prolina.
ES2016602B3 (es) Anillo del estancamiento del ranurador.
NO872765L (no) Beta-laktam-sammensetning, og framgangsmaate for framstilling av denne.
NO881014D0 (no) Xylometazolinholdige, farmasoeytiske midler.
DE3763944D1 (de) 4-phenylthiazol-derivate.